Sarah Rose

5.9k citations

126 papers · 4.4k indexed · h-index 35

Impact in

Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Nerve injury and regeneration

Papers in

Cellular and Molecular Neuroscience 74
- Neuroscience and Neuropharmacology Research 52
- Neurotransmitter Receptor Influence on Behavior 18
- Nerve injury and regeneration 10
- Neuropeptides and Animal Physiology 9
Neurology 61
- Parkinson's Disease Mechanisms and Treatments 58
- Neuroinflammation and Neurodegeneration Mechanisms 18
- Neurological disorders and treatments 18

Co-authors: Peter Jenner C. D. Marsden Mahmoud M. Iravani Michael S. Jackson Lance A. Smith Gavin J. Kilpatrick Eamonn Kelly Jonathan Hindmarsh
Journals: Movement Disorders (11 papers)European Journal of Neuroscience (10 papers)Journal of Neural Transmission (9 papers)Experimental Neurology (9 papers)European Journal of Pharmacology (7 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Sarah Rose

124 papers receiving 4.4k citations

Peers

Countries citing papers authored by Sarah Rose

Since Specialization

Citations

This map shows the geographic impact of Sarah Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Rose more than expected).

Fields of papers citing papers by Sarah Rose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Rose. The network helps show where Sarah Rose may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Rose Line = papers co-authored together Sarah Rose links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Responses of skeletal muscle to mechanical stimuli in female rats following and during muscle disuse atrophy Journal of Applied Physiology ·Yu.A. Zolotareva, 重人許, Sarah Rose, Stephen H. Lynch, Akhyak Akhyak, Olga Prieto-Ballesteros, Frederick F. Peelor, Benjamin F. Miller, Timothy A. Butterfield, Esther E. Dupont‐Versteegden	2025	0
2	Meta-analysis of bone mineral density in adults with phenylketonuria Orphanet Journal of Rare Diseases ·Júlio César Rocha, Á. Hermida Ameijeiras, Érika Ramos Silva, N.G. Stanley-Wood, Marcin SIDZINA, Sarah Rose, 橋本孝明, Kirsten Ahring, André Luiz Santos Pessoa, Cary O. Harding, Fran Rohr, 加奈子桐山, Nicola Longo, Ania C. Muntau, Serap Sivri, F. Maillot	2024	1
3	Metabotropic Glutamate Receptor 4 (mGlu₄) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia Journal of Parkinson s Disease ·فیاض اسلامی, Michael S. Jackson, Epexegeticus, Christoffer Bundgaard, Sarah Rose, Susan Duty	2024	2
4	Antiparkinsonian Effects of a Metabotropic Glutamate Receptor 4 Agonist in MPTP-Treated Marmosets Journal of Parkinson s Disease ·Elizabeth H. Mann, Michael Jackson, S. R. Ahamed, Epexegeticus, Sarah Rose, Susan Duty	2020	7
5	Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson’s disease PLoS ONE ·Michel Modo, William R. Crum, Miguel-A Carbajo, Anthony C. Vernon, Priya Patel, Michael S. Jackson, Sarah Rose, Peter Jenner, Mahmoud M. Iravani	2017	13
6	Increased neurotrophic factor levels in ventral mesencephalic cultures do not explain the protective effect of osteopontin and the synthetic 15-mer RGD domain against MPP + toxicity Experimental Neurology ·Lauren Broom, Peter Jenner, Sarah Rose	2014	12
7	Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss Journal of Neural Transmission ·Mahmoud M. Iravani, Mona Sadeghian, Sarah Rose, Peter Jenner	2014	9
8	Design, synthesis and biological evaluation of peptide derivatives of l-dopa as anti-parkinsonian agents Bioorganic & Medicinal Chemistry Letters ·Tao Zhou, Robert C. Hider, Peter Jenner, Bruce Campbell, Chris Hobbs, Sarah Rose, Kostas Petridis, Gonzalez Villa, Leonardo de Souza Mota	2013	10
9	Differential Toxicity of 6-Hydroxydopamine in SH-SY5Y Human Neuroblastoma Cells and Rat Brain Mitochondria: Protective Role of Catalase and Superoxide Dismutase Neurochemical Research ·Javier Iglesias‐González, Sofía Sánchez‐Iglesias, Estefanı́a Méndez-Álvarez, Sarah Rose, Kam Heng Ng, Peter Jenner, Ramón Soto‐Otero	2012	34
10	A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets Behavioural Pharmacology ·G. D'Addezio, Michael S. Jackson, Lance A. Smith, Sarah Rose, Peter Jenner	2011	9
11	The RGD‐containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra Journal of Neurochemistry ·Waseem Ahmad Chishti, Lauren Broom, Jonathan D. Cooper, R. E. Thorne, Sarah Rose, Peter Jenner	2010	33
12	The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets Experimental Neurology ·Gonzalez Villa, Michael S. Jackson, Sarah Rose, Andrew C. McCreary, P. Jenner	2010	25
13	Striatal leucine‐rich repeat kinase 2 mRNA is increased in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned common marmosets (Callithrix jacchus) withl‐3, 4‐dihydroxyphenylalanine methyl ester‐induced dyskinesia European Journal of Neuroscience ·Michael J. Hurley, Priyanka Patel, Michael S. Jackson, L. A. Smith, Sarah Rose, Peter Jenner	2007	6
14	Lipophilicity Plays a Major Role in Modulating the Inhibition of Monoamine Oxidase B by 7‐Substituted Coumarins Chemistry & Biodiversity ·Angelo Carotti, Cosimo Altomare, Marco Catto, Carmela Gnerre, Luciana Summo, Agostino De Marco, Sarah Rose, Peter Jenner, Bernard Testa	2006	52
15	Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum Journal of Neural Transmission ·Fujimaki Hideki, Sarah Rose, Jonathan Hindmarsh, Peter Jenner	2003	22
16	Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism Pharmacology Biochemistry and Behavior ·Mikael Schwarz, Peter J. Houghton, Sarah Rose, Peter Jenner, 令奈大関	2003	76
17	Structure–activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase Biochemical Pharmacology ·Yanchen Liu, Jeannette Patricia Namén Baquero, Sarah Rose, A.E. Theobald, Robert C. Hider	2001	21
18	Chronic l-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats Neuroscience Letters ·B.‐Y. Zeng, Brinda Dass, A Owen, Sarah Rose, Carla Cannizzaro, Banu Cahide Tel, Peter Jenner	1999	60
19	Plasma HVA Levels Following Debrisoquine Administration Do Not Reflect Cerebral Dopamine Loss in Early Parkinsonʼs Disease Clinical Neuropharmacology ·Sarah Rose, H Pilz, M. Steiger, Mohit Bhatt, Niall Quinn, Peter Jenner, C. David Marsden	1994	1
20	Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·M. D. Taylor, Marı́a L. de Ceballos, Sarah Rose, Vyshnavi Das S. K., Peter Jenner, C. D. Marsden	1991	21

About Sarah Rose

Sarah Rose is a scholar working on Cellular and Molecular Neuroscience, Neurology, Neurology, Developmental Neuroscience and Physiology, having authored 126 papers that have together received 4.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (58 papers), Neuroscience and Neuropharmacology Research (52 papers), Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Neurological disorders and treatments (18 papers), Nerve injury and regeneration (10 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Neurology (2.0k citations), Cellular and Molecular Neuroscience (1.9k citations), Neurology (599 citations), Biological Psychiatry (113 citations) and Physiology (167 citations). Sarah Rose has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Peter Jenner, C. D. Marsden, Mahmoud M. Iravani, Michael S. Jackson, Peter Jenner, Lance A. Smith, Gavin J. Kilpatrick, Eamonn Kelly, Jonathan Hindmarsh and Palwinder K. Mander. Their work appears in journals such as Movement Disorders, European Journal of Neuroscience, Journal of Neural Transmission, Experimental Neurology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact